Dolby Laboratories (DLB) Liabilities and Shareholders Equity (2009 - 2026)

Dolby Laboratories (DLB) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $3.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 1.23% year-over-year to $3.2 billion; the trailing twelve-month figure through Jun 2026 stood at $12.8 billion (up 1.04% YoY), and the FY2025 full-year result was $3.2 billion, up 3.79% from the prior year.
• Liabilities and Shareholders Equity fell to $3.2 billion in Q2 2026 per DLB's latest filing, from $3.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $3.2 billion in Q1 2026 and bottomed at $2.7 billion in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $3.0 billion across 5 years, with a median of $3.1 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity slipped 13.4% in 2022, then grew 10.79% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $2.7 billion in 2022, then rose by 6.8% to $2.9 billion in 2023, then grew by 7.6% to $3.2 billion in 2024, then gained by 1.06% to $3.2 billion in 2025, then fell by 1.11% to $3.2 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.2 billion, $3.2 billion, and $3.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.